Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
about
Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivHLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseasesExploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1Editing of the HLA-DR-peptide repertoire by HLA-DMPeptide vaccines and peptide libraries.The connection domain is implicated in metalloporphyrin binding and inhibition of HIV reverse transcriptase.A new hybrid resin for stepwise screening of peptide libraries combined with single bead Edman sequencing.Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket.Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infectionModel for the peptide-free conformation of class II MHC proteins.Flanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pocketsCrystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.High-throughput engineering and analysis of peptide binding to class II MHCInteraction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) regionPlasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinationsDirect binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models.HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-livesSpecificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitisPeptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis associationArginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosyMHC class II proteins and disease: a structural perspective.T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38-kDA autoantigen recognized by T cells from an insulin-dependent diabetic patient.Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.Interaction of allergens, major histocompatibility complex molecules, and T cell receptors: a 'ménage à trois' that opens new avenues for therapeutic intervention in type I allergy.Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization.Human CD4+ T cell response to human herpesvirus 6.A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.Factors governing the binding and recognition of foreign and self-peptides by MHC class II.Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules.Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif.Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II moleculesAllele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.HIV-1 variation diminishes CD4 T lymphocyte recognition.Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
P2860
Q24673986-2BA60638-4997-4CF9-A87F-7BC874646054Q24679388-AD9615C3-5BB4-458C-9CB0-C5CD9EE41BF4Q27641946-BFBD2FCB-CC94-4EC2-A12E-1AEFB5248B01Q28613148-8FBF5927-C660-450A-B26C-6FC16CA4BC9CQ30992372-E4F242CB-E2D7-4312-BF2A-DF819C1D7014Q31938029-7F44CE29-9F0F-485E-A352-013F1B0BBE37Q32049808-2665577E-184A-4861-9132-A2C977C5F9F6Q33258637-29AB01FD-B76B-4A9D-B9A6-AF49B6F370DFQ33302672-4707461D-9F6E-4784-9918-F9C66A53A51FQ33342783-9D5B8478-E225-48A5-B08B-D0615FD1373CQ33377255-257CAE70-24CA-4407-8CE5-024851FF235AQ33575103-CE8AA68E-0F6B-476A-8E83-AA2CA316C9FEQ33630225-DADDAB47-D25E-4677-85B5-C8D25FED8A4BQ33887531-A45CD22D-5D1A-4125-BD85-CCFF77512EEAQ34125960-3D74CCB8-9D7D-4E7F-8594-7783E45D6A04Q34140188-D695244A-8F61-42D9-855A-55C885D9E793Q35235094-F908E741-22EE-4F3A-830E-713D35738276Q35310089-6C2B3528-DC1A-469D-8D93-71B96DFCA51FQ36288434-2E635396-90E2-4104-A318-65593432757CQ36303660-4816027B-4351-4185-A8B7-D765FB13411EQ36361966-FA1904CA-885A-4B1F-9D15-64E269B1C95DQ36364632-2A081128-92D2-46B4-8761-C882A2D3477FQ36364795-C3A02DB4-AFD0-45EC-8D27-5800FB530A08Q36365951-C7072A6A-6DCF-4F34-A89A-92B5DCF67FAFQ36430136-C6E83951-3695-493D-A8CD-85BC7A24FA4AQ36807112-A9385045-221E-4A9C-9BE3-1B89D302F53FQ37494529-1044916D-F219-4EEE-8A9F-0AEA9E8B51C5Q37513302-F7F09BFB-D307-4A11-938D-548203F8CE90Q37859218-118A9414-B4D1-44FF-BC63-81B930CA24C7Q38235847-C549A155-0918-40AA-AB75-8E0195BAAE62Q39392116-D7BF8BFD-A17F-4A52-898D-22B5A6B6F80BQ39843966-72D0C8F7-D218-4C17-BA09-5A346695916FQ40217254-F7C9E807-1FDB-4F5C-9059-D3E37994478CQ40729404-EDAE6CFC-C18E-4133-AFC6-EE98736926D0Q40945287-7A15755A-2A8C-4AE4-9640-AC765008A5ECQ40955892-2A1C2027-CEFA-47E6-89EA-DC947D426BCBQ41372991-1F960FA9-7281-4EC8-B6AA-23C5F8BD549CQ41444149-4A2C8A9C-CB28-41FD-877C-39519DBEDDA6Q41811611-131ACFD1-6DC6-466A-9AD8-9B923FBCCA03Q42011739-C28FEF39-C704-43AE-9F63-18F22AA05679
P2860
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
@ast
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
@en
type
label
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
@ast
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
@en
prefLabel
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
@ast
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
@en
P2093
P2860
P356
P1476
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
@en
P2093
P2860
P304
P356
10.1084/JEM.176.4.1007
P407
P577
1992-10-01T00:00:00Z